The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Taking stem cells to the clinic: Major challenges
Open accessAbstract
Stem cell therapy offers tremendous promise in the treatment of many incurable diseases. A variety of stem cell types are being studied but human embryonic stem cells (hESCs) appear to be the most versatile as they are pluripotent and can theoretically differentiate into all the tissues of the human body via the three primordial germ layers and the male and female germ lines. Currently, hESCs have been successfully converted in vitro into functional insulin secreting islets, cardiomyocytes, and neuronal cells and transfer of such cells into diabetic, ischaemic, and parkinsonian animal models respectively have shown successful engraftment. However, hESC‐derived tissue application in the human is fraught with the problems of ethics, immunorejection, tumorigenesis from rogue undifferentiated hESCs, and inadequate cell numbers because of long population doubling times in hESCs. Human mesenchymal stem cells (hMSC) though not tumorigenic, also have their limitations of multipotency, immunorejection, and are currently confined to autologous transplantation with the genuine benefits in allogeneic settings not conclusively shown in large controlled human trials. Human Wharton's jelly stem cells (WJSC) from the umbilical cord matrix which are of epiblast origin and containing both hESC and hMSC markers appear to be less troublesome in not being an ethically controversial source, widely multipotent, not tumorigenic, maintain “stemness” for several serial passages and because of short population doubling time can be scaled up in large numbers. This report describes in detail the hurdles all these stem cell types have to overcome before stem cell‐based therapy becomes a genuine reality. J. Cell. Biochem. 105: 1352–1360, 2008. © 2008 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cao, F., Lin, S., Xie, X., Ray, P., Patel, M., Zhang, X., Drukker, M., Dylla, S. J., Connolly, A. J., Chen, X., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.588954 · Cited by 493
Regulatory networks define phenotypic classes of human stem cell lines
Müller, F.-J., Laurent, L. C., Kostka, D., Ulitsky, I., Williams, R., Lu, C., Park, I.-H., Rao, M. S., Shamir, R., Schwartz, P. H., et al. (2008) · Nature · doi:10.1038/nature07213 · Cited by 343 · cited 1×
“Through such an analysis it is evident that genomic similarities and differences surface between stem cell lines, sources, and types [International Stem Cell Initiative, 2007; Muller et al., 2008].”
Background
Cited by
Biomaterial strategies for engineering implants for enhanced osseointegration and bone repair
Agarwal, R., & García, A. J. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.03.013 · Cited by 789
Alzheimer’s disease and its treatment by different approaches: A review
Srivastava, S., Ahmad, R., & Khare, S. K. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113320 · Cited by 467
Fong, C.-Y., Chak, L.-L., Biswas, A., Tan, J.-H., Gauthaman, K., Chan, W.-K., & Bongso, A. (2011) · Stem Cell Reviews and Reports · doi:10.1007/s12015-010-9166-x · Cited by 345
Self-citationProkhorova, T. A., Harkness, L. M., Frandsen, U., Ditzel, N., Schrøder, H. D., Burns, J. S., & Kassem, M. (2009) · Stem Cells and Development · doi:10.1089/scd.2007.0266 · Cited by 277
Effects of hypoxic culture conditions on umbilical cord-derived human mesenchymal stem cells
Lavrentieva, A., Majore, I., Kasper, C., & Hass, R. (2010) · Cell Communication and Signaling · doi:10.1186/1478-811x-8-18 · Cited by 241
Metadata
- Authors
- Bongso, A., Fong, C., & Gauthaman, K.
- Venue
- Journal of Cellular Biochemistry
- Publisher
- Wiley
- Published
- 2008-11-03
- Volume
- 105
- Issue
- 6
- Pages
- 1352-1360
- ISSN
- 0730-2312 (ISSN-L)
- 1097-4644
- OpenAlex
- W2146990552
- Cited by
- 183
- References
- 2
- FWCI
- 4.47
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.